It looks like Reckitt’s baby formula saga is set to continue for a while. The company’s Illinois-based unit was recently ordered by a jury to shell out a hefty $60 million (€55 million) payment to Jasmine Watson, the mother of a premature infant son who passed away following developing a bowel disease allegedly caused by baby formula Enfamil. Enfamil, produced by Reckitt’s American infant formula arm Mead Johnson, is believed to cause necrotising enterocolitis (NEC) – the disease that Watson’s son died from – which mainly affects premature babies and is fatal about 15% to 40% of the time. More…